Leukemia drug nilotinib safe, shows promise against Alzheimer's disease in trial
Thursday, May 28, 2020 - 23:30
in Health & Medicine
The leukemia drug nilotinib, which shows promise in reducing the effects of Alzheimer's disease, is safe and has minimal side effects when used at low doses, according to a small clinical trial published Friday.